Protein arginine methylation: from enigmatic functions to therapeutic targeting

Q Wu, M Schapira, CH Arrowsmith… - Nature reviews Drug …, 2021 - nature.com
Protein arginine methyltransferases (PRMTs) are emerging as attractive therapeutic targets.
PRMTs regulate transcription, splicing, RNA biology, the DNA damage response and cell …

Methionine metabolism in health and cancer: a nexus of diet and precision medicine

SM Sanderson, X Gao, Z Dai, JW Locasale - Nature Reviews Cancer, 2019 - nature.com
Methionine uptake and metabolism is involved in a host of cellular functions including
methylation reactions, redox maintenance, polyamine synthesis and coupling to folate …

[HTML][HTML] PRMT5 function and targeting in cancer

H Kim, AR Ze'ev - Cell stress, 2020 - ncbi.nlm.nih.gov
Protein methyl transferases play critical roles in numerous regulatory pathways that underlie
cancer development, progression and therapy-response. Here we discuss the function of …

[HTML][HTML] Role of protein arginine methyltransferase 5 in human cancers

W Xiao, X Chen, L Liu, Y Shu, M Zhang… - Biomedicine & …, 2019 - Elsevier
Protein arginine methyltransferases (PRMTs) play important roles in protein methylation.
PRMT5 is the major type II arginine methyltransferase that catalyzes the transfer of two …

[HTML][HTML] Protein arginine methyltransferases as therapeutic targets in hematological malignancies

C Sauter, J Simonet, F Guidez, B Dumétier, B Pernon… - Cancers, 2022 - mdpi.com
Simple Summary This review summarizes the current findings about the cellular roles of
protein arginine methyltransferases (PRMTs) in the formation of blood cells from stem cell …

[HTML][HTML] Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer

X Yang, Z Zeng, X Jie, Y Wang, J Han, Z Zheng, J Li… - Cancer letters, 2022 - Elsevier
Radioresistance is regarded as the main cause of local recurrence and distant metastasis in
non-small cell lung cancer. However, the underlying mechanisms of radioresistance …

PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival

X Lu, TM Fernando, C Lossos… - Blood, The Journal …, 2018 - ashpublications.org
The germinal center (GC) reaction plays an important role in generating humoral immunity
and is believed to give rise to most B-cell lymphomas. GC entry and exit are tightly regulated …

PRMT5: a putative oncogene and therapeutic target in prostate cancer

E Beketova, JL Owens, AM Asberry, CD Hu - Cancer gene therapy, 2022 - nature.com
Abstract Protein arginine methyltransferase 5 (PRMT5) was discovered two decades ago.
The first decade focused on the biochemical characterization of PRMT5 as a regulator of …

[HTML][HTML] PRMT5 as a potential therapeutic target in MYC-amplified medulloblastoma

D Kumar, S Jain, DW Coulter, SS Joshi, NK Chaturvedi - Cancers, 2023 - mdpi.com
Simple Summary Medulloblastoma is the most prevalent intracerebellar pediatric brain
tumor, accounting for approximately 20% of all childhood brain tumors and over 60% of …

[HTML][HTML] Targeting PRMT5 activity inhibits the malignancy of hepatocellular carcinoma by promoting the transcription of HNF4α

BN Zheng, CH Ding, SJ Chen, K Zhu, J Shao… - Theranostics, 2019 - ncbi.nlm.nih.gov
Background: Liver cancer stem cells (LCSCs) are responsible for the initiation, progression
and chemoresistance of liver cancer. However, no agent targeting LCSC is available in the …